Healthpeak Properties (NYSE:DOC) Given New $20.00 Price Target at Wells Fargo & Company

Healthpeak Properties (NYSE:DOC) had its price target reduced by Wells Fargo & Company from $22.00 to $20.00 in a research note released on Monday,Benzinga reports. They currently have an equal weight rating on the real estate investment trust’s stock.

Several other equities analysts have also recently issued reports on the company. Evercore ISI decreased their price objective on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Scotiabank decreased their price objective on Healthpeak Properties from $23.00 to $21.00 and set a “sector outperform” rating for the company in a report on Monday, May 12th. Wedbush decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Wall Street Zen cut Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Thursday, May 1st. Finally, Argus reissued a “buy” rating and issued a $25.00 price objective on shares of Healthpeak Properties in a report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and a consensus price target of $23.27.

Healthpeak Properties Stock Performance

Shares of DOC opened at $17.41 on Monday. The stock has a 50-day moving average of $18.10 and a two-hundred day moving average of $19.67. Healthpeak Properties has a one year low of $16.64 and a one year high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a market cap of $12.09 billion, a P/E ratio of 49.73, a P/E/G ratio of 2.17 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts’ consensus estimates of $0.46. The company had revenue of $702.89 million during the quarter, compared to analysts’ expectations of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm’s revenue was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.45 EPS. As a group, research analysts predict that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were paid a dividend of $0.1017 per share. The ex-dividend date was Monday, May 19th. This represents a yield of 7.05%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 305.00%.

Insiders Place Their Bets

In other news, Director Tommy G. Thompson acquired 5,777 shares of the business’s stock in a transaction on Wednesday, May 28th. The stock was bought at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the purchase, the director now owns 144,290 shares in the company, valued at approximately $2,491,888.30. This represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Scott M. Brinker purchased 11,337 shares of the company’s stock in a transaction dated Monday, April 28th. The stock was bought at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the transaction, the chief executive officer now directly owns 201,863 shares of the company’s stock, valued at approximately $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders bought 29,764 shares of company stock worth $521,909. Corporate insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

A number of large investors have recently made changes to their positions in the stock. Strs Ohio purchased a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $41,939,000. Intrua Financial LLC grew its position in shares of Healthpeak Properties by 5.9% in the first quarter. Intrua Financial LLC now owns 59,419 shares of the real estate investment trust’s stock valued at $1,201,000 after purchasing an additional 3,304 shares in the last quarter. Geneos Wealth Management Inc. grew its position in shares of Healthpeak Properties by 54.4% in the first quarter. Geneos Wealth Management Inc. now owns 8,566 shares of the real estate investment trust’s stock valued at $173,000 after purchasing an additional 3,017 shares in the last quarter. Focus Partners Wealth grew its position in shares of Healthpeak Properties by 53.0% in the first quarter. Focus Partners Wealth now owns 79,971 shares of the real estate investment trust’s stock valued at $1,617,000 after purchasing an additional 27,689 shares in the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $220,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.